|


TEL: +32 16 58 90 45
Fax :+ 32 16 50 90 45
GENTAUR Europe
tel+32 2 732 5688
fax+32 2 732 4414
Av.
de l' Armée 68
B-1040 BRUSSELS
BELGIUM

GENTAUR France
tel 01 43 25
01 50
fax01 43 25
01 60
9, rue
Lagrange
75005 PARIS
FRANCE

GENTAUR Italy
tel 02 36 00
65 93
fax 02 36 00
65 94
20135 MILANO
ITALY

GENTAUR Germany
tel +49 241
6085 13140
fax +49 241
6085 33033
Forckenbeckstraße 6,
D-52074
Aachen
GERMANY
| |
Resistin and Resistin-Like
Molecules (RELMs or FIZZ1-3)
or Adipocyte-Specific Secretory Factor (ADSF) Proteins Antibodies
Obesity, a common nutritional disorder, is associated with diabetes,
hypertension, hyperlipidemia, cancer and many other health related problems.
Regulation of body weight depends upon the calorie intake and expenditure. It is
a very complex and highly regulated process. It involves multiples neural
circuits with specific neuropeptides, neurotransmitter transporters and
receptors and influenced by peripheral signals. Resistance to insulin
characterizes type 2 diabetes, the most common form of diabetes. There is a
strong link between type 2 diabetes and obesity, as most patients tend to be
obese. Adipose tissue is the major organ involved in energy storage and
mobilization. Adipocyte produces several key regulatory proteins such as
leptin, adipsin, Acrp30/AdipoQ, TNF-alpha,
adipocyte fatty acid binding protein (aFABP) and
Pref-1 (an inhibitor or adipocyte differentiation)
that are involved in obesity. Thiozolidinediones (TZDs), a new class of
anti-diabetic, enhances target-tissue sensitivity to insulin. A screen of genes
down regulated by TZD in adipocyte led to the discovery of a new protein hormone
called resistin (for resistance to insulin).
Resistin, specifically produced and secreted by adipocyte, is present at
elevated levels in the blood of obese animals, and is down regulated by fasting
and anti-diabetic drugs. Antibody to resistin stimulated glucose uptake and
improved insulin sensitivity in obese mice. Some other protein related to
resistin has been called resistin-related molecules (RELM-alpha
and beta). Resistin family of proteins was also identified as proteins (FIZZ1-3,
for Found in Inflammatory zone) involved in allegory and inflammation.
Resistin is also described as serine/cysteine-rich Adipocyte-Specific Secretory
Factor (ADSF or FIZZ3). Resistin (pre peptide
length: human 108 aa; mouse/rat 114 aa; mol wt ~12.5 kDa) is characterized by
the presence of a hydrophobic signal peptide that is cleaved before its
secretion. Resistin proteins show ~55% homology in human and mouse. It is 45-55%
related to
FIZZ1 (RELM-alpha) and FIZZ2
(RELM-beta). Resistin family of proteins show 10 Cys with the consensus
sequence at the C-terminus CX11CX8CX4CX3CX10CX7CX8CX9CC. Resistin is
specifically expressed in white adipose tissues including inguinal and
epididymal fats and also in brown adipose tissue.
RELM-alpha/FIZZ1/PMNG1 (Parasite-induced
Macrophage Novel Gene 1 (prepeptides: mouse/rat 111 aa; ~77% identity) is
63% related to resistin at the C-terminus (38 aa). The N-terminus of RELM-alpha
is less conserved at the N-terminus. RELM-alpha mRNA was most abundant in white
adipose tissue. It is also expressed in mammary tissue with significant fat
pads. Unlike resistin, RELM-alpha is not expressed in 3T3-L1 adipocyte or in
preadipocytes. It is also found in heart, lung and tongue, where resistin is
absent. In mice, RELM-alpha/FIZZ1 is found at low levels in a subset of
bronchial epithelial cells and in non-neuronal cells adjacent neurovascular
bundles in the peribronchial stroma, and in the wall of the large and small
bowel. FIZZ1 expression is induced hypertrophic, hyperplastic bronchial
epithelium.
RELM-beta/FIZZ2 (prepeptides: mouse 105 aa; human
11 aa ~45-65% identity with FIZZ1 and 2) is highly related to resistin at the
C-terminus region. Its expression is most abundant in colon (proximal and distal
colon) but not in white adipose tissue. In mouse, RELM-beta is also detected at
low levels in cecum and ileum. In min mouse (mouse model for human familial
adenomatosus polyposis), RELM-beta expression was markedly increased in tumors
immediately adjacent to normal tissue.
ADI
has made antibodies to resistin, RELM-alpha, and RELM-beta using antigenic
peptide sequences unique to each proteins. Control imunogenic/blocking peptides
are also available to study the specificity of antibodies.
|
Antibodies to |
Antigen peptide location |
Antibody Host |
* Expected Ab Crossreactivity |
Unpurified Antisera
Cat # (100 ul) |
Aff. Pure IgG/Mab
Cat # (100 ug) |
* Control Peptide Cat#
(100 ug) |
|
Resistin/FIZZ3 (ab# 1) |
M, 14 aa, ~NT |
Rb, poly |
M, R, H |
RSTN11-S |
RSTN11-A |
RSTN11-P |
|
Resistin/FIZZ3 (ab# 2) |
H, 14 aa ~NT |
Rb, poly |
H |
RSTN12-S |
RSTN12-A |
RSTN12-P |
|
Resistin/FIZZ3 ab #3 |
H, Protein |
Rb, poly |
H (M, R?) |
RSTN13-S |
|
|
|
Resistin/FIZZ3 ab #4 |
H, Protein |
m, mono |
|
- |
RSTN14-M |
|
|
Resistin/FIZZ3 ab #5 |
M, Protein |
r, mono |
|
|
RSTN15-M |
|
|
Resistin/FIZZ3 ab #6
|
M, Protein |
G, poly |
Biotinylated-Goat Anti-mouse
resistin protein IgG, aff pure
Cat # RSTN18-BTN; 50 ug
|
|
Resistin/ADSF/FIZZ3
Protein Control |
Mouse Recombinant Resistin
protein (inactive) WB+Ve control,Cat # RSTN11-C; 100 ul
Human Recombinant Resistin protein (inactive) WB+Ve control,Cat # RSTN12-C;
100 ul |
|
Resistin/ADSF/FIZZ3
Pure Protein |
Mouse Recombinant, purified
Resistin protein (active)
Cat # RSTN15-R-5; 5 ug; (cat #
RSTN15-R-25; 25 ug)
Human Recombinant, purified Resistin protein (active)
Cat # RSTN16-R; 5 ug (cat #
RSTN16-R-25; 25 ug) |
|
Resistin ELISA kits |
Human Resistin ELISA kit
for measuring Resistin in Serum, Cat # 100-110-RSH
Mouse Resistin ELISA kit for measuring Resistin in Serum, Cat #
100-120-RSM |
|
RELM-alpha/FIZZ1 (ab# 1) |
M, 14 aa ~NT |
Rb, poly |
M (R?) |
RELMA11-S |
RELMA11-A |
RELMA11-P |
|
RELM-alpha/FIZZ1 (ab# 2) |
H, 13 aa ~NT |
Rb, poly |
M (R?) |
RELMA12-S |
RELMA12-A |
RELMA12-P |
|
RELM-beta/FIZZ2 (ab# 1) |
M, 14 aa ~NT |
Rb, poly |
M (R, H?) |
RELMB21-S |
RELMB21-A |
RELMB21-P |
|
RELM-beta/FIZZ2 |
Mouse Recombinant RELM-beta
protein (inactive) WB+Ve control,
Cat # RELMB26-C; 100ul
Mouse Recombinant, purified RELM-beta protein (active) , Cat # RELMB26-R-5;
5 ug,
Mouse Recombinant, purified RELM-beta protein (active), Cat # RELMB26-R-25,
25 ug |
|
RELM-beta/FIZZ2 (ab# 2) |
H, 14 aa ~NT |
Rb, poly |
H (M, R?) |
RELMB22-S |
RELMB22-A |
RELMB22-P |
|
RELM-beta/FIZZ2 |
Human Recombinant RELM-beta
protein (inactive) WB+Ve control, Cat # RELMB22-C;
Human Recombinant, purified RELM-beta protein (active), Cat # RELMB25-R-5; 5
ug,
Human Recombinant, purified RELM-beta protein (active), Cat # RELMB25-R-25,
25 ug |
|
Control IgGs For use as -ve
controls in ELISA, Western, IHC. |
Control Mouse IgG (non immune),
Cat # 20008-1 (1 mg)
Control Rabbit IgG (non immune) , Cat # 20009-1 (1 mg)
Control Goat IgG (non immune), Cat # 20011-1 (1 mg) |
M= Mouse; R=Rat; H=Human; Rb=Rabbit; G=goat; B=Bovine, MO=Monkey; P=pig; CT=
near C-terminus; NT=near N-terminus; Internal=Middle of protein.
EC=extracellular; CP=cytoplasmic domains *
** Expected antibody crossreactivity information is mostly based upon high
(>70%) sequence conservation of antigenic/control peptides in various species.
When antibody crossreactivity has actually been experimentally confirmed in
various species, it will be mentioned in the appropriate data sheets.
"Neat Antisera or antisera" are the
unpurified antiserum and it is suitable for ELISA and Western.
"Affinity pure"
IgG may be more suitable for immunohistochemical (IHC) applications and to
reduce background in most immunological applications including ELISA and
Western.
"Control peptides" can not be used for
Western as they are very short peptides. They are intended for ELISA or antibody
blocking studies to establish antibody specificity.
Western blot +ve protein controls, where available, are semi-pure, pure or
recombinant proteins that are formulated in SDS-PAGE sample buffer. They are
recommended to be used for Western (load 10 ul/lane) for visulaization with
antibodies
|